Small Pharma is evaluating the best way to administer N,N-dimethyltryptamine (DMT) in a therapeutic setting for the treatment of depressive disorders. DMT—the primary psychoactive compound in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback